全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Kei Takamura , Yasutaka Kawai ...
来源:[J].Cancer Chemotherapy and Pharmacology(IF 2.795), 2017, Vol.80 (5), pp.955-963Springer
摘要:A high proportion of patients with wild-type EGFR non-small cell lung cancer (NSCLC) receive third-line therapy and beyond, with no prospective randomized trials addressing the issue. This study aimed to select the most suitable regimen as a third- or fourth-line therapy for wild...
作者:Kei Takamura , Toshiyuki Harada ...
来源:[J].Lung Cancer(IF 3.392), 2019, Vol.138, pp.65-71Elsevier
摘要:Abstract(#br)Objectives(#br)Patients with concomitant advanced non-small cell lung cancer (NSCLC) and interstitial lung disease (ILD) are excluded from most clinical chemotherapy trials because of the high risk of exacerbating the latter condition. This study prospectively i...
作者:Kei Takamura , Toshiyuki Harada ...
来源:[J].Lung Cancer(IF 3.392), 2019, Vol.138, pp.65-71Elsevier
摘要:Abstract(#br)Objectives(#br)Patients with concomitant advanced non-small cell lung cancer (NSCLC) and interstitial lung disease (ILD) are excluded from most clinical chemotherapy trials because of the high risk of exacerbating the latter condition. This study prospectively i...
作者:Kei Takamura , Tetsuya Kojima ...
来源:[J].Lung Cancer(IF 3.392), 2015, Vol.90 (3), pp.548-553Elsevier
摘要:Abstract(#br)Objectives(#br)Several American and Japanese guidelines recommend surgery for patients with c-stage I small-cell lung cancer (SCLC), whereas the European Society of Medical Oncology (ESMO) guidelines recommend surgery for patients with not only c-stage I but als...
作者:Kei Takamura , Kunihiko Kobayashi ...
来源:[J].Lung Cancer(IF 3.392), 2014, Vol.86 (2), pp.195-200Elsevier
摘要:Abstract(#br)Objectives(#br)Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors are particularly effective in non-small cell lung cancer (NSCLC) patients harboring active EGFR mutations. However, some studies have reported survival benefits in NSCLC patients with w...
作者:Kei Takamura , Satoshi Oizumi ...
来源:[J].Cancer Chemotherapy and Pharmacology(IF 2.795), 2014, Vol.74 (6), pp.1149-1157Springer
摘要:Abstract(#br) Purpose(#br)This phase II study evaluated the response rate (RR) and safety of combination therapy with carboplatin (CBDCA) and pemetrexed (PEM) in Japanese patients with non-squamous non-small cell lung cancer (non-sq NSCLC). Further, the relationship between ...
作者:Kei Takamura , Masayuki Hanaoka ...
来源:[J].Respirology(IF 2.781), 2015, Vol.20 (5), pp.805-812Wiley
摘要:Abstract(#br)Background and objective(#br)Pulmonary hypertension ( PH ) is often associated with respiratory diseases, but only a small number of patients present with severe PH defined as mean pulmonary arterial pressure ≥ 35 mm Hg. We here conducted a multicenter, retrospe...
作者:Kei Takamura , Sinji Sakaue ...
来源:[J].Journal of Diabetes and Its Complications(IF 2.056), 2002, Vol.16 (5), pp.352-358Elsevier
摘要:Abstract(#br)To clarify the influence of blood glucose level or diabetes mellitus on serum KL-6, a mucin-like glycoprotein, concentrations, they were measured against 176 diabetic subjects, including receiving insulin (INS) group ( n =54), oral antidiabetics (OAD) group ( n ...
作者:... Yasuyuki Nasuhara , Kei Takamura , Yoshikazu Kawakami
来源:[J].Allergology International, 2001, Vol.50 (1), pp.109-111Elsevier
摘要:ABSTRACT(#br)A 63-year-old man was referred to our hospital because of a dry cough. His chest roentgenogram revealed ground-glass opacities and honeycomb formations bilaterally in the lower lung fields. Pulmonary function tests showed a depleted lung volume and decreased art...
作者:Kei TAKAMURA , Katsura NAGAI ...
来源:[J].Respirology(IF 2.781), 2004, Vol.9 (2), pp.249-254Wiley
摘要:Objective: Recent studies have shown that theophylline may exert anti‐inflammatory effects on neutrophils. We undertook to assess the effect of theophylline on airway inflammation in COPD.(#br)Methodology: We performed a 4‐week randomized double‐blind, placebo‐controlle...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×